A six month pilot study conducted by molecular dermatology and research innovator Hair DX, suggests that certain genetic mechanisms can help predict if the breakthrough hair loss drug Propecia (Finasteride), primary prescribed to men, could actually be effective in the treatment of female pattern hair loss in post menopausal women.
“Results of our pilot study are very encouraging, as it appears we have found a key piece of the genetic puzzle which identifies women who can benefit from Finasteride therapy in the same way men do. Our findings suggest these women actually have a female corollary to male pattern hair loss (Androgenetic Alopecia), and that is an important finding,” says IAHRS Accepted Member Dr. Sharon Keene, Chief Medical Officer of HairDX. “Once these results are confirmed, it can usher in a new era of treatment for female Androgenetic Alopecia.”
Read Full Story:
No Comments